References
- Jimenez S. A., Hitraya E., Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996; 22: 647–74
- Zhu Y., Liu X., Skold C. M., Wang H., Kohyama T., Wen F. Q., et al. Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three‐dimensional collagen gels. Respir Res 2001; 2: 300–5
- Janoff A. Elastase in tissue injury. Annu Rev Med 1985; 36: 207–16
- Le Roy E. C., Black C., Fleischmajer R. Scleroderma: classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5
- Valentini G., Silman A. J., Veale D. Assessment of disease activity. Clin Exp Rheumatol 2003; 21((3 Suppl 29))S39–41
- Medsger T. A Jr., Bombardieri S., Czirjak L., Scorza R., Della Rossa A., Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21((3 Suppl 29))S42–6
- Nakajima K., Powers J. C., Ashe B. M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1‐protease inhibitor reactive site. J Biol Chem 1979; 254: 4027–32
- Ploug M., Gardsvoll H., Jorgensen T. J., Lonborg Hansen L., Dano K. Structural analysis of the interaction between urokinase‐type plasminogen activator and its receptor: a potential target for anti‐invasive cancer therapy. Biochem Soc Trans 2002; 30: 177–83
- Lijnen H. R. Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems. Fibrinol Proteol 2000; 14: 175